Study of Docetaxel or Vinorelbine Plus Cisplatin in Neoadjuvant Chemoradiotherapy for Esophageal Cancer (NEOCRTEC308)
Phase 3 Unknown
610 enrolled
Envafolimab Combined With Abraxane and Cisplatinas as Neoadjuvant Treatment for Resectable Esophageal Cancer
Phase 2 Unknown
33 enrolled
Carrelizumab Combined With Chemotherapy for Adjuvant Therapy of Esophageal Squamous Cell Carcinoma
Phase 2 Unknown
23 enrolled
Neoadjuvant Therapy of Camrelizumab Combined With Chemotherapy for Resectable Locally Advanced Esophageal Squamous Cell Carcinoma
Phase 2 Unknown
39 enrolled
Sintilimab in Combination With Chemotherapy in Neoadjuvant Treatment of Potentially Resectable Esophageal Cancer
Phase 2 Unknown
30 enrolled
A Study of Anti-PD-L1 Antibody in Neoadjuvant Chemotherapy of Esophageal Squamous Cell Carcinoma.
Phase 1/2 Unknown
70 enrolled
REVO
Phase 2 Unknown
92 enrolled
Study of Camrelizumab (SHR-1210) in Combination With Concurrent Chemoradiotherapy in Locally Advanced Esophageal Cancer
Phase 3 Unknown
396 enrolled
TQB2450 Solution for Injection (TQB2450)+Paclitaxel+Cisplatin ± Anlotinib in the Treatment of Esophageal Cancer.
Phase 2 Unknown
48 enrolled
PET Imaging-guided Chemoradiotherapy in Esophageal Squamous Cell Carcinoma
Phase 2 Unknown
216 enrolled
Phase II/III Study Compare Adjuvant Chemoradiotherapy, Radiotherapy and Surgery Alone for Esophageal Carcinoma
Phase 2/3 Unknown
360 enrolled
T+TP
Phase 2 Unknown
44 enrolled
SCOPE2
Phase 2/3 Unknown
584 enrolled
xenoZ
Unknown
120 enrolled
Neoadjuvant Chemotherapy Followed by Preoperative Chemoradiation in Resectable Squamous-cell Esophageal Cancer
Phase 2 Unknown
48 enrolled
Paclitaxel, Cisplatin,5-FU vs. Radiotherapy Plus Paclitaxel, Cisplatin as Preoperative Therapy for Locally Advanced ESC
Phase 3 Unknown
420 enrolled
Docetaxol Plus Cisplatin Versus 5-Fu Plus Cisplatin as 1st-line Chemotherapy in Advanced ESCC Patients
Phase 3 Unknown
358 enrolled
Definitive Concurrent Chemoradiotherapy With Docetaxel Plus Cisplatin Versus 5-fluorouracil Plus Cisplatin in Patients With Esophageal Squamous Cell Carcinoma
Phase 2 Unknown
120 enrolled
Adjuvant Therapies or Surgery Alone for High Risk pN0 Esophageal Cancer
Phase 3 Unknown
486 enrolled
Autologous Tumor Tissue Antigen-sensitized DC-CIK Cells Combined With Chemotherapy for Esophageal Cancer
Phase 2 Unknown
60 enrolled
Concurrent Radiotherapy and Weekly Chemotherapy of PF for Postoperative Locoregional Recurrence of Esophageal Cancer
Phase 2 Unknown
46 enrolled
Concurrent Chemoradiotherapy Containing Paclitaxel&Cisplatin With/Without Tarceva in Locally Advanced Esophageal Cancer
Phase 3 Unknown
344 enrolled
Study of Tissue Samples in Predicting How Well Chemotherapy and Radiation Therapy Will Kill Cancer Cells in Patients With Squamous Cell Carcinoma of the Esophagus
Phase NA Unknown
160 enrolled
Combination Chemotherapy in Treating Patients With Esophageal Cancer
Phase 3 Unknown
1,300 enrolled
Chemotherapy and Radiation Therapy in Treating Patients With Cancer of the Esophagus
Phase 3 Unknown
326 enrolled
Cisplatin, Capecitabine, and Radiation Therapy With or Without Cetuximab in Treating Patients With Esophageal Cancer
Phase 2/3 Unknown
259 enrolled
S-1, Cisplatin, and Radiation Therapy in Treating Patients With Stage IIA, Stage III, or Stage IVA Esophageal Cancer That Can Be Removed by Surgery
Phase 2 Unknown
32 enrolled
DCXAIOCHARITE
Phase 2 Unknown
50 enrolled
Combination of Chemoradiation Therapy and Epitope Peptide Vaccine Therapy in Treating Patients With Esophageal Cancer
Phase 1 Unknown
9 enrolled
Cetuximab/Paclitaxel/Cisplatin Concurrent Chemoradiotherapy Followed by Esophagectomy for Loco-regional Esophageal Cancer
Phase 2 Unknown
62 enrolled
Fluorouracil, Irinotecan, Leucovorin, and Cisplatin as First-Line Therapy in Treating Patients With Metastatic Esophageal Cancer
Phase 2 Unknown